Suppr超能文献

1 型糖尿病患者长期胰肾联合移植后骨密度的进展。

Bone mineral density progression following long-term simultaneous pancreas-kidney transplantation in type-1 diabetes.

机构信息

Division of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário do Porto, Largo Professor Abel Salazar 4099-001 Porto, Portugal.

Division of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário do Porto, Largo Professor Abel Salazar 4099-001 Porto, Portugal.

出版信息

Ann Endocrinol (Paris). 2023 Aug;84(4):454-459. doi: 10.1016/j.ando.2023.03.002. Epub 2023 Mar 15.

Abstract

INTRODUCTION

Simultaneous pancreas-kidney transplantation (SPKT) has demonstrated favorable impact on the progression of chronic complications in type-1 diabetes (T1D) and terminal chronic kidney disease (CKD). However, some CKD mineral and bone disorders (CKD-MBD) may persist, even after transplantation. There are only a few studies addressing the long-term progression of bone mineral density (BMD) in these patients. Our aim was to assess baseline BMD and long-term progression and consequences in patients with T1D undergoing SPKT.

METHODS

A retrospective cohort included patients undergoing SPKT in our tertiary center between 2000 and 2017. BMD progression was assessed on dual X-ray absorptiometry (DXA). Only patients with baseline data and a minimum follow-up of 2 years were included.

RESULTS

Seventy-three patients were included, 53.4% male, with a median age at SPKT of 35 years (interquartile range [IQR] 31; 39). At transplantation, the median T-scores for the lumbar spine (LS) and femoral neck (FN) were -1.6 (IQR -2.6; -1.1) and --2.1 (IQR -2.7; -1.6), respectively. Seventy-five percent of patients presented low BMD (osteopenia or osteoporosis) in the LS and 90% in the FN, with 33% osteoporosis in the LS and 36% in the FN. On multivariate analysis, male gender (odds ratio [OR] 10.82, 95% confidence interval (CI) 2.88-40.70) and low body-mass index (BMI) (OR 0.73, 95% CI 0.55-0.97) were significantly associated with lumbar but not femoral osteoporosis. At long-term follow-up, BMD significantly improved in the LS (ΔT-score +0.41, P<0.001) and FN (ΔT-score +0.29, P=0.01), at a median 4 years after SPKT. Twelve (16.4%) and 9 (12.3%) patients showed persistent FN and LS osteoporosis, respectively. Multivariate linear regression showed that high BMI was predictive of improvement in BMD.

CONCLUSIONS

This study demonstrated severe skeletal fragility in T1D patients with terminal CKD undergoing SPKT, more than a quarter of whom showed osteoporosis. The significant improvement in BMD may result from metabolic correction by SPKT and from physiological skeleton mineralization, which continues in this age group. BMD progression was positively associated with BMI, due to improved nutritional balance after transplantation.

摘要

简介

在 1 型糖尿病(T1D)和终末期慢性肾脏病(CKD)患者中,同期胰腺-肾脏移植(SPKT)对慢性并发症的进展有积极影响。然而,一些 CKD 矿物质和骨代谢紊乱(CKD-MBD)可能持续存在,即使在移植后也是如此。只有少数研究探讨了这些患者的骨密度(BMD)的长期进展。我们的目的是评估 T1D 患者接受 SPKT 后的基线 BMD 以及长期进展和后果。

方法

回顾性队列研究纳入了 2000 年至 2017 年期间在我们的三级中心接受 SPKT 的患者。通过双能 X 线吸收法(DXA)评估 BMD 进展。仅纳入有基线数据且随访时间至少 2 年的患者。

结果

共纳入 73 例患者,其中 53.4%为男性,SPKT 时的中位年龄为 35 岁(四分位距[IQR]31;39)。移植时,腰椎(LS)和股骨颈(FN)的 T 评分中位数分别为-1.6(IQR-2.6;-1.1)和-2.1(IQR-2.7;-1.6)。75%的患者 LS 存在低骨密度(骨量减少或骨质疏松症),90%的患者 FN 存在低骨密度,33%的患者 LS 存在骨质疏松症,36%的患者 FN 存在骨质疏松症。多因素分析显示,男性(比值比[OR]10.82,95%置信区间[CI]2.88-40.70)和低体重指数(BMI)(OR 0.73,95%CI 0.55-0.97)与腰椎但不是股骨骨质疏松症显著相关。在长期随访中,SPKT 后中位 4 年时,LS(T 评分增加 0.41,P<0.001)和 FN(T 评分增加 0.29,P=0.01)的 BMD 显著改善。12(16.4%)和 9(12.3%)例患者分别持续存在 FN 和 LS 骨质疏松症。多元线性回归显示,高 BMI 可预测 BMD 改善。

结论

这项研究表明,终末期 CKD 行 SPKT 的 T1D 患者骨骼脆弱严重,超过四分之一的患者存在骨质疏松症。BMD 的显著改善可能是由于 SPKT 纠正了代谢紊乱,并在该年龄组继续进行生理性骨骼矿化。BMD 进展与 BMI 呈正相关,这归因于移植后营养平衡的改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验